Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
28,237
Total Claims
$5.0M
Drug Cost
14,091
Beneficiaries
$356
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-55%
Opioid rate vs peers
1.2% vs 2.6% avg
-67%
Cost per patient vs peers
$356 vs $1,068 avg
+563%
Brand preference vs peers
59.7% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.2%
Opioid Rate
330
Opioid Claims
$7,982
Opioid Cost
8.5%
Long-Acting Rate
Brand vs Generic
Brand: 16,780 claims · $4.8M
Generic: 11,349 claims · $206K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 8,559 | $2.8M |
| Rsv Vacc, Pref A And Pref B/Pf | 2,149 | $710K |
| Varicella-Zoster Ge/As01b/Pf | 3,208 | $701K |
| Apixaban | 550 | $174K |
| Mirabegron | 109 | $43K |
| Diphth,pertuss(Acell),tet Vac | 572 | $38K |
| Hepatitis A And B Vaccine/Pf | 255 | $38K |
| Dulaglutide | 29 | $23K |
| Fluticasone/Vilanterol | 55 | $23K |
| Rivaroxaban | 90 | $20K |
| Insulin Aspart | 93 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 106 | $17K |
| Insulin Lispro | 52 | $15K |
| Sitagliptin Phosphate | 24 | $12K |
| Empagliflozin | 24 | $12K |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About